Skip to footer


  • TCS Research’s innovative microbiome-based solutions can be utilized to monitor health status of an individual, and to predict the risk of several asymptomatic diseases at an early stage.
  • Variations in the bacterial communities residing within us can serve as diagnostic biomarkers and foretell the presence of a disease.
    The team has captured these patterns of imbalances to develop microbiome-based diagnostic markers.
  • In addition to predict the risk of preterm delivery, the team has developed microbiome-based biomarkers for accurate screening of colorectal and breast cancer.